Previous 10 | Next 10 |
Doximity to Release Fiscal 2022 First Quarter Results on August 10, 2021 PR Newswire SAN FRANCISCO , July 20, 2021 /PRNewswire/ -- Doximity, Inc. (NYSE: DOCS) will announce financial results for its first quarter which ended June 30, 2021 after market cl...
solarseven/iStock via Getty Images Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calenda...
Gainers: Clene (CLNN) +8%, Inhibikase Therapeutics (IKT) +7%, ASLAN Pharmaceuticals (ASLN) +5%, Doximity (DOCS) +5%.Losers: IMV (IMV) -26%, Tempest Therapeutics (TPST) -25%, Sonoma Pharmaceuticals (SNOA) -23%, Immunic (IMUX) -18%, Virpax ...
Doximity was listed on the NYSE on June 24, 2021, and its last traded price as of July 12, 2021 is still close to double that of its IPO price. Doximity is a leader in the healthcare professional social networking market in the country, and its management team has had relevant experie...
Doximity, sometimes known as the LinkedIn for doctors, IPO'd recently, and the share price jumped. Doximity has a high-quality business model and offers lots of products and services to doctors, which is why I am interested. However, after an 80% IPO day increase, I am likely wait...
Doximity Inc. Class A (NYSE:DOCS) traded at a new 52-week high today of $65.42. Approximately 1.8 million shares have changed hands today, as compared to an average 30-day volume of 835,000 shares. Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platfor...
Doximity Inc. Class A (NYSE:DOCS) traded at a new 52-week high today of $57.98. Approximately 958,000 shares have changed hands today, as compared to an average 30-day volume of 743,000 shares. Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform pr...
With so many stories happening at once in the financial markets -- inflation, jobs, meme stocks, cryptocurrency -- it would have been easy to miss the initial public offering (IPO) of a fast-growing digital platform for doctors. Investors who overlook it might be missing a transformational ...
Whether you think it is more like Facebook or LinkedIn, there's no denying that Doximity (NYSE: DOCS) is making a name for itself in digitizing the world of medicine. In this episode of Industry Focus: Wildcard , join Motley Fool contributor Brian Feroldi and Motley Fool...
As the LinkedIn for doctors, Doximity has massive potential to be a dominant player in the telehealth market. Its main value proposition is its network of medical professionals. Teladoc's struggle is Doximity's opportunity. Doximity exhibits phenomenal financial performance. ...
News, Short Squeeze, Breakout and More Instantly...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Doximity, Inc. (NYSE: DOCS). On August 8, 2023, the Company disclosed disappointing guidance ...
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2024 after market close on August 8, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p...
2024-07-10 22:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...